Publications
Cox, E.,Wade, R., Péron, M., Dietz, K.C., Eastwood, A., Palmer, S. and Griffin, S., 2019. The clinical and cost effectiveness of Inotuzumab Ozogamicin for the treatment of adult relapsed or refractory B-cell acute lymphoblastic leukaemia : an evidence review group evaluation of a NICE single technology appraisal. Pharmacoeconomics, 37(9), pp.1081-1091.
Péron, M., Llewellyn, A., Moe-Byrne, T., Walker, S., Walton, M., Harden, M., Palmer, S. and Simmonds, M., 2018. Adjunctive colposcopy technologies for assessing suspected cervical abnormalities : systematic reviews and economic evaluation. Health technology assessment, pp.1-260.
Dormont, B. and Péron, M., 2016. Does health insurance encourage the rise in medical prices ? A test on balance billing in France. Health economics, 25(9), pp.1073-1089.
Working papers
Péron, M. and Dormont, B., 2018. Heterogeneous moral hazard in Supplementary Health Insurance. HEDG Working Paper
Journal referee
European Journal of Health Economics, Health Economics, International Journal of Health Economics and Management, Value in Health